Business
Healthscope hospitals change hands, but not fortunes
The private hospital chain found its latest buyers in the ICU
|
HMC Capital
8 articles
Finance
Di Pilla's power pothole
Yet more tumult for HMC Capital, as its energy transition strategy follows its hospital and data centre funds into the market doghouse.
|
Finance
Healthscope's problem was private equity
As the US experience demonstrates, PE and hospitals are a terrible mix.
|
Business
Is Vik Bansal on the move?
Eternally unfulfilled, Boral's CEO is baiting all the hooks that he can.
|
Business
Todd Sampson's departure and dancing with David Di Pilla
Qantas' loss of Todd Sampson went unmourned while HMC Capital's investor day intrigued the market.
|
Finance
Chemist Warehouse’s Di Pilla di lution
The numbers are in on Chemist Warehouse’s reverse takeover of Sigma. Cheap hindsight tells us that a regular IPO would’ve cost Chemist Warehouse shareholders $100 million, but saved them $3 billion.
|